The tariff classification of a retinal imaging instrument from Taiwan
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the retinol imaging instrument will be 9018.19.9550, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[i]nstruments and appliances used in medical, surgical, dental or veterinary sciences …: [e]lectro-diagnostic apparatus …: [o]ther: [o]ther: [o]ther: [o]ther apparatus.” The general rate of duty will be free.
Ruling text
In your letter dated August 14, 2025, you requested a tariff classification ruling. The merchandise under consideration is a fully assembled retinal imaging instrument. It is a complete, standalone ophthalmic diagnostic device designed to capture high-resolution images of the human retina for use in medical screenings and examinations.
It consists of an outer housing (made of an aluminum alloy with plastic components), an optical system (lenses, mirrors, and optical sensors for retinal imaging), optomechanics (3 axis motorized optical bench), electronics (circuit boards, imaging sensor array, display/control interfaces, and microcontroller), and embedded software.
The principle use of the device is non-invasive medical imaging of the retina to assist in diagnosis and monitoring of eye diseases such as diabetic retinopathy, macular degeneration, and glaucoma. Upon import, you state the instrument is fully functional and capable of performing retinal imaging independently. When powered, the device captures high-resolution retinal images for subsequent review by a healthcare provider.
After import, the instrument will be mounted and integrated into a self-service health screening kiosk located in various settings. The kiosk enclosure, stand, and related hardware are not part of this ruling. In your letter, you suggest classification under 9018.50.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for other ophthalmic instruments and appliances and parts and accessories thereof. We disagree.
The Explanatory Notes (EN) for heading 9018 lists three categories of ophthalmic instruments: surgical, diagnostic, and orthoptic or sight testing apparatus. This is an indication that the drafters of the EN believed that diagnostic apparatus are an identifiable category of ophthalmic instruments. Subheading 9018.50 describes other ophthalmic instruments and appliances.
Thus, other ophthalmic instruments and apparatus in subheading 9018.50 can include only ophthalmic apparatus which are other than those provided for at the same subheading level in heading 9018, including an ophthalmic instrument or apparatus which is an electro-diagnostic apparatus, within subheading 9018.11 through 9018.19. The retinal imaging instrument is an ophthalmic diagnostic device and more specifically provided in subheading 9 018.19, HTSUS.
The applicable subheading for the retinol imaging instrument will be 9018.19.9550, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[i]nstruments and appliances used in medical, surgical, dental or veterinary sciences …: [e]lectro-diagnostic apparatus …: [o]ther: [o]ther: [o]ther: [o]ther apparatus.” The general rate of duty will be free.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time, products of Taiwan will be subject to an additional ad valorem rate of duty of 20 percent.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N352478).